Clair Scientific ApS
Nøgletal
- Afkastningsgrad
- -35,9 %
- Egenkapitalforrentning
- -28,8 %
- Likviditetsgrad
- 1.565,9 %
- Soliditetsgrad
- 95,6 %
Resultat
| Regnskabsperiode | |
|---|---|
Bruttoresultat | 241.541 |
Driftsresultat | -3.569.093 |
Finansielle indtægter | 14.332 |
Finansielle omkostninger | 5.056 |
Skat af årets resultat | -819.209 |
Årets resultat | -2.740.608 |
Medarbejdere
| Regnskabsperiode | |
|---|---|
Gns. ansatte | 6 |
Personaleomkostninger | 3.810.634 kr. |
Balance
| Regnskabsperiode | |
|---|---|
Likvider | 4.980.201 |
Kortfristede aktiver | 6.180.288 |
Langfristede aktiver | 3.774.687 |
Aktiver i alt | 9.954.975 |
Egenkapital | 9.512.144 |
Forpligtelser i alt | 442.831 |
Kortfristede forpligtelser | 394.678 |
Arbejdskapital
| Regnskabsperiode | |
|---|---|
Varebeholdninger | 623.907 |
Andre kortfristede tilgodehavender | 97.139 |
Leverandørgæld | 104.013 |
Kapital og udbytte
| Regnskabsperiode | |
|---|---|
Selskabskapital | 53.894 |
Overført resultat | 6.580.017 |
Investeringer og aktiver
| Regnskabsperiode | |
|---|---|
Langfristede investeringer og tilgodehavender | 84.645 |
Højdepunkter fra årsrapporten
Forretning og udvikling
Description of key activities of the companyClair Scientific develops and commercializes quantitative phase imaging (QPI) microscopy systems and software for non-destructive measurement and analysis of biological samples and materials. The company's core technology platform enables label-free, high-resolution phase imaging of living cells, tissues, and other specimens. Primary applications include research in cell biology and biophysics, pre-clinical and quality assurance workflows in pharmaceutical and life science manufacturing, and emerging applications in materials science and industrial quality control. The company sells microscope systems, accessories, and related services to academic institutions, contract research organizations, and commercial partners. Product development, technical support, and go-to-market activities constitute the primary operational focus.
Significant changes in the company's activities and financial mattersThe gross profit for the year totals DKK 242thousand against DKK 2.002thousand last year. Profit or loss from ordinary activities after tax totals DKK -2.741thousand against DKK 570thousand last year. Management considers the net profit or loss for the year satisfactory.
Risici og væsentlige forhold
Events occurring after the end of the financial yearNo events of material significance to the annual report for 2025 have occured after the balance sheet date.
Forpligtelser og sikkerhedsstillelser
5.Contractual obligations and contingencies, etc.
DKK in thousands…
Se op til 9 års regnskabshistorik ved at oprette en gratis bruger
Opret gratis bruger